• 1
    Valent P, Sperr WR, Schwartz LB, Horny HP. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol 2004;114:311.
  • 2
    Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:1056010564.
  • 3
    Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG et al. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312314.
  • 4
    Rueff F, Placzek M, Przybilla B. Mastocytosis and hymenoptera venom allergy. Curr Opin Allergy Clin Immunol 2006;6:284288.
  • 5
    Dubois AE. Mastocytosis and hymenoptera allergy. Curr Opin Allergy Clin Immunol 2004;4:291295.
  • 6
    Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D et al. Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and raised serum tryptase. J Allergy Clin Immunol 2009; 123: 680686.
  • 7
    Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res. 1966;3:331333.
  • 8
    Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391397.
  • 9
    Kucharewicz I, Bodzenta-Lukaszyk A, Szymanski W, Mroczko B, Szmitkowski M. Basal serum tryptase level correlates with severity of hymenoptera sting and age. J Investig Allergol Clin Immunol 2007;17:6569.
  • 10
    Torres MJ, Blanca M, Fernandez J, Romano A, De Weck A, Aberer W et al. Diagnosis of Immediate allergic reactions to beta-lactam antibiotics. Allergy 2004;59:11531160.
  • 11
    Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J et al. European network for drug allergy (ENDA). Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854863.
  • 12
    Brockow K, Romano A. Skin tests in the diagnosis of drug hypersensitivity. Current pharmaceutical drugs 2008;14:27782791.
  • 13
    Sperr WR, Escribano L, Jordan JH, Schernthaner GH, Kundi M, Horny HP et al. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001;25:529536.
  • 14
    Akin C. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 2006;8:412419.
  • 15
    De Olano DG, De La Hoz Caballer B, Núñez López R, Sanchez Munoz L, Cuevas Augustin M, Diguez L et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 2007;37:15471555.
  • 16
    Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;63:226232.
  • 17
    Kränke B, Sturm G, Aberer W. Negative venom skin test results and mastocytosis. J Allergy Clin Immunol 2004;113:180181.